Roundhill GLP-1 & Weight Loss ETF Rating $25.72 +0.13 (+0.51%) As of 07/3/2025 11:51 AM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Roundhill GLP-1 & Weight Loss ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.OZEM Aggregate RatingModerate Buy 2.67Holdings in OZEM have an aggregate rating of Moderate Buy based on 386 analyst ratings issued in the past year covering 28 companies (140.7% of the portfolio).OZEM Aggregate Price Target$25.72High Prediction$25.72Average Prediction$25.72Low Prediction$25.72Holdings in OZEM have an aggregate price target of $25.72 and a range of $25.72 to $25.72 covering 28 companies (140.7% of the portfolio).OZEM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy12 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Roundhill GLP-1 & Weight Loss ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 28 OZEM Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings18.23%NVONovo Nordisk A/S$69.05-1.1%4.7104 of 5 stars2.27$112.00 62.2%11Positive News18.23%NVONovo Nordisk A/S$69.05-1.1%4.7104 of 5 stars2.27$112.00 62.2%11Positive News15.92%LLYEli Lilly and Company$779.60+0.0%4.9885 of 5 stars2.75$1,011.61 29.8%20Trending News15.92%LLYEli Lilly and Company$779.60+0.0%4.9885 of 5 stars2.75$1,011.61 29.8%20Trending News4.06%GPCRStructure Therapeutics$20.62+0.9%2.6818 of 5 stars3.00$76.17 269.4%74.06%GPCRStructure Therapeutics$20.62+0.9%2.6818 of 5 stars3.00$76.17 269.4%74.02%PFEPfizer$25.45+0.5%4.9793 of 5 stars2.45$28.55 12.2%22Trending News4.02%PFEPfizer$25.45+0.5%4.9793 of 5 stars2.45$28.55 12.2%22Trending News3.96%VKTXViking Therapeutics$28.16+1.6%4.2736 of 5 stars3.00$87.15 209.5%14Trending NewsInsider Trade3.96%VKTXViking Therapeutics$28.16+1.6%4.2736 of 5 stars3.00$87.15 209.5%14Trending NewsInsider Trade3.65%ALTAltimmune$4.76-2.9%2.2271 of 5 stars3.00$19.00 299.2%63.65%ALTAltimmune$4.76-2.9%2.2271 of 5 stars3.00$19.00 299.2%63.49%MTSRMetsera$29.45+2.0%N/A3.00$55.00 86.8%53.49%MTSRMetsera$29.45+2.0%N/A3.00$55.00 86.8%53.43%AZNAstraZeneca$69.60-2.2%2.3144 of 5 stars2.83$85.00 22.1%6News CoveragePositive News3.43%AZNAstraZeneca$69.60-2.2%2.3144 of 5 stars2.83$85.00 22.1%6News CoveragePositive News3.08%AMGNAmgen$298.25+0.5%4.5229 of 5 stars2.35$307.82 3.2%23Positive News3.08%AMGNAmgen$298.25+0.5%4.5229 of 5 stars2.35$307.82 3.2%23Positive News2.49%TERNTerns Pharmaceuticals$4.23-0.7%3.931 of 5 stars2.60$15.63 269.4%52.49%TERNTerns Pharmaceuticals$4.23-0.7%3.931 of 5 stars2.60$15.63 269.4%52.41%REGNRegeneron Pharmaceuticals$545.00-0.5%4.9562 of 5 stars2.80$813.57 49.3%252.41%REGNRegeneron Pharmaceuticals$545.00-0.5%4.9562 of 5 stars2.80$813.57 49.3%252.06%SRRKScholar Rock$35.35-0.6%3.3413 of 5 stars3.14$42.67 20.7%72.06%SRRKScholar Rock$35.35-0.6%3.3413 of 5 stars3.14$42.67 20.7%71.87%GILDGilead Sciences$111.28-0.2%4.8402 of 5 stars2.78$110.55 -0.7%27Positive NewsInsider Trade1.87%GILDGilead Sciences$111.28-0.2%4.8402 of 5 stars2.78$110.55 -0.7%27Positive NewsInsider Trade1.68%BHVNBiohaven$14.63-0.9%3.4101 of 5 stars3.07$58.46 299.6%151.68%BHVNBiohaven$14.63-0.9%3.4101 of 5 stars3.07$58.46 299.6%15 This page (NASDAQ:OZEM) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s BIGGEST setup yet.After another undefeated quarter, “Market Wizard” Larry Benedict is sounding the alarm on a $194 trillion mark...Brownstone Research | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roundhill GLP-1 & Weight Loss ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Roundhill GLP-1 & Weight Loss ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OZEM Stock Alerts